[HTML][HTML] Risk of pneumonia in obstructive lung disease: A real-life study comparing extra-fine and fine-particle inhaled corticosteroids

S Sonnappa, R Martin, E Israel, D Postma… - PLoS …, 2017 - journals.plos.org
Background Regular use of inhaled corticosteroids (ICS) in patients with obstructive lung
diseases has been associated with a higher risk of pneumonia, particularly in COPD. The …

[HTML][HTML] Risk of pneumonia in obstructive lung disease: A real-life study comparing extra-fine and fine-particle inhaled corticosteroids

S Sonnappa, R Martin, E Israel, D Postma… - PLoS ONE, 2017 - ncbi.nlm.nih.gov
Background Regular use of inhaled corticosteroids (ICS) in patients with obstructive lung
diseases has been associated with a higher risk of pneumonia, particularly in COPD. The …

[PDF][PDF] Risk of pneumonia in obstructive lung disease: A real-life study comparing extra-fine and fine-particle inhaled corticosteroids

S Sonnappa, R Martin, E Israel, D Postma… - PLoS …, 2017 - pdfs.semanticscholar.org
Background Regular use of inhaled corticosteroids (ICS) in patients with obstructive lung
diseases has been associated with a higher risk of pneumonia, particularly in COPD. The …

Risk of pneumonia in obstructive lung disease: A real-life study comparing extra-fine and fine-particle inhaled corticosteroids.

S Sonnappa, R Martin, E Israel, D Postma… - PLoS …, 2017 - search.ebscohost.com
Background: Regular use of inhaled corticosteroids (ICS) in patients with obstructive lung
diseases has been associated with a higher risk of pneumonia, particularly in COPD. The …

[PDF][PDF] Risk of pneumonia in obstructive lung disease: A real-life study comparing extra-fine and fine-particle inhaled corticosteroids

S Sonnappa, R Martin, E Israel, D Postma… - PloS ONE, 2017 - aura.abdn.ac.uk
Background Regular use of inhaled corticosteroids (ICS) in patients with obstructive lung
diseases has been associated with a higher risk of pneumonia, particularly in COPD. The …

[引用][C] Risk of pneumonia in obstructive lung disease: A real-life study comparing extra-fine and fine-particle inhaled corticosteroids

S Sonnappa, R Martin, E Israel, D Postma… - PLoS …, 2017 - ui.adsabs.harvard.edu
Risk of pneumonia in obstructive lung disease: A real-life study comparing extra-fine and
fine-particle inhaled corticosteroids - NASA/ADS Now on home page ads icon ads Enable full …

Risk of pneumonia in obstructive lung disease: A real-life study comparing extra-fine and fine-particle inhaled corticosteroids

S Sonnappa, R Martin, E Israel, D Postma… - PloS …, 2017 - abdn.elsevierpure.com
BACKGROUND: Regular use of inhaled corticosteroids (ICS) in patients with obstructive
lung diseases has been associated with a higher risk of pneumonia, particularly in COPD …

Risk of pneumonia in obstructive lung disease: A real-life study comparing extra-fine and fine-particle inhaled corticosteroids

S Sonnappa, RM Martin, E Israel, D Postma… - PLoS ONE, 2017 - research.rug.nl
Background Regular use of inhaled corticosteroids (ICS) in patients with obstructive lung
diseases has been associated with a higher risk of pneumonia, particularly in COPD. The …

Risk of pneumonia in obstructive lung disease: A real-life study comparing extra-fine and fine-particle inhaled corticosteroids

S Sonnappa, R Martin, E Israel, D Postma… - PLoS ONE, 2017 - go.gale.com
Background Regular use of inhaled corticosteroids (ICS) in patients with obstructive lung
diseases has been associated with a higher risk of pneumonia, particularly in COPD. The …

Risk of Pneumonia in Obstructive Lung Disease: A Real-Life Study Comparing Extra-Fine and Fine-Particle Inhaled Corticosteroids

S Sonnappa, RJ Martin, E Israel, DS Postma… - PLoS ONE, 2017 - dash.harvard.edu
Background Regular use of inhaled corticosteroids (ICS) in patients with obstructive lung
diseases has been associated with a higher risk of pneumonia, particularly in COPD. The …